HUMA: Humacyte, Inc. Stock

by  •  • Comments Off on HUMA: Humacyte, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 609.16
Enterprise Value ($M) 650.71
Book Value ($M) -63.72
Book Value / Share -0.51
Price / Book -9.56
NCAV ($M) -155.48
NCAV / Share -1.24
Price / NCAV -3.92

Profitability (mra)
Return on Invested Capital (ROIC) -9.76
Return on Assets (ROA) -1.02
Return on Equity (ROE) -4.13

Liquidity (mrq)
Quick Ratio 1.10
Current Ratio 1.10

Balance Sheet (mrq) ($M)
Current Assets 23.00
Assets 114.76
Liabilities 178.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G BlackRock, Inc. 6.30 0.00
09-03 13D/A Niklason Laura E 6.30 -16.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 871,011 2,842,730 30.64
2024-11-14 2,360,354 7,652,665 30.84
2024-11-13 504,905 1,729,949 29.19
2024-11-12 591,048 2,273,991 25.99
2024-11-11 594,408 2,795,587 21.26

(click for more detail)

Similar Companies
HALO – Halozyme Therapeutics, Inc. HLVX – HilleVax, Inc.
HOWL – Werewolf Therapeutics, Inc. IBRX – ImmunityBio, Inc.
IDXX – IDEXX Laboratories, Inc.


Financial data and stock pages provided by
Fintel.io